| Univariate | Multivariatea | ||
---|---|---|---|---|
 | HR (95% CI) | p-value | HR (95% CI) | p-value |
Serum sodium level | Â | Â | Â | Â |
 Categorical model |  |  |  |  |
 <138.0 mEq/L | 3.20 (1.54–6.64) | 0.002 | 2.36 (1.10–5.04) | 0.027 |
 138.0 – 140.0 mEq/L | 2.07 (0.98–4.40) | 0.058 | 2.11 (0.99–4.51) | 0.054 |
 >140.0 mEq/L | 1 (ref) |  | 1 (ref) |  |
 Continuous model (per 1 mEq/L) | 0.86 (0.79–0.94) | <0.001 | 0.90 (0.81–0.99) | 0.040 |
Age (per 5 years) | 1.06 (0.95–1.18) | 0.318 |  |  |
Female (vs male) | 1.31 (0.78–2.22) | 0.313 |  |  |
Body mass index (per 1 kg/m2) | 0.99 (0.91–1.07) | 0.711 |  |  |
Smoking history | 1.52 (0.90–2.56) | 0.120 |  |  |
Inability to ambulate or transfer | 4.79 (2.61–8.80) | <0.001 | 2.10 (0.90–4.91) | 0.086 |
Comorbid conditions | Â | Â | Â | Â |
 Diabetes mellitus | 1.66 (0.99–2.80) | 0.056 |  |  |
 Hypertension | 0.65 (0.28–1.51) | 0.313 |  |  |
 Cardiovascular disease | 2.54 (1.51–4.27) | <0.001 | 2.21 (1.30–3.75) | 0.003 |
 Peripheral vascular disease | 1.83 (0.66–5.07) | 0.243 |  |  |
 Cerebrovascular disease | 1.65 (0.86–3.19) | 0.135 |  |  |
 Chronic liver disease | 1.08 (0.49–2.39) | 0.846 |  |  |
 Cancer | 1.01 (0.46–2.23) | 0.976 |  |  |
Dialysis vintage (per 12 months) | 0.98 (0.95–1.01) | 0.242 |  |  |
IDWL (per 1% of body weight) | 1.05 (0.86–1.28) | 0.651 |  |  |
Vascular access | Â | Â | Â | Â |
 Fistula | 1 (ref) |  | 1 (ref) |  |
 Graft or catheter | 4.08 (2.33–7.15) | <0.001 | 2.95 (1.57–5.55) | 0.001 |
Laboratory data | Â | Â | Â | Â |
 Hemoglobin (per 1 g/dL) | 0.80 (0.59–1.08) | 0.140 |  |  |
 Serum albumin (per 1 g/dL) | 0.16 (0.07–0.37) | <0.001 | 0.47 (0.15–1.45) | 0.186 |
 Serum creatinine (per 1 mg/dL) | 0.84 (0.76–0.92) | <0.001 | 0.97 (0.86–1.10) | 0.654 |
 Serum β2-microglobulin (per 5 mg/dL) | 1.26 (1.01–1.57) | 0.037 |  |  |